FTRE
Price
$9.68
Change
+$0.03 (+0.31%)
Updated
Aug 29, 04:00 PM (EDT)
Capitalization
876.22M
80 days until earnings call
RIGL
Price
$38.76
Change
-$0.55 (-1.40%)
Updated
Aug 29, 04:16 PM (EDT)
Capitalization
705.12M
Interact to see
Advertisement

FTRE vs RIGL

Header iconFTRE vs RIGL Comparison
Open Charts FTRE vs RIGLBanner chart's image
Fortrea Holdings
Price$9.68
Change+$0.03 (+0.31%)
Volume$6.86K
Capitalization876.22M
Rigel Pharmaceuticals
Price$38.76
Change-$0.55 (-1.40%)
Volume$100
Capitalization705.12M
FTRE vs RIGL Comparison Chart in %
Loading...
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FTRE vs. RIGL commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTRE is a Buy and RIGL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (FTRE: $9.65 vs. RIGL: $39.31)
Brand notoriety: FTRE and RIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FTRE: 99% vs. RIGL: 157%
Market capitalization -- FTRE: $876.22M vs. RIGL: $705.12M
FTRE [@Biotechnology] is valued at $876.22M. RIGL’s [@Biotechnology] market capitalization is $705.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FTRE’s FA Score shows that 0 FA rating(s) are green whileRIGL’s FA Score has 0 green FA rating(s).

  • FTRE’s FA Score: 0 green, 5 red.
  • RIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, RIGL is a better buy in the long-term than FTRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FTRE’s TA Score shows that 3 TA indicator(s) are bullish while RIGL’s TA Score has 3 bullish TA indicator(s).

  • FTRE’s TA Score: 3 bullish, 4 bearish.
  • RIGL’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, FTRE is a better buy in the short-term than RIGL.

Price Growth

FTRE (@Biotechnology) experienced а +24.60% price change this week, while RIGL (@Biotechnology) price change was -6.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.74%. For the same industry, the average monthly price growth was +15.52%, and the average quarterly price growth was +29.97%.

Reported Earning Dates

FTRE is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (-0.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FTRE($876M) has a higher market cap than RIGL($705M). RIGL YTD gains are higher at: 133.710 vs. FTRE (-48.257). RIGL has higher annual earnings (EBITDA): 109M vs. FTRE (-858.4M). RIGL has more cash in the bank: 108M vs. FTRE (81.2M). RIGL has less debt than FTRE: RIGL (61M) vs FTRE (1.24B). FTRE has higher revenues than RIGL: FTRE (2.73B) vs RIGL (268M).
FTRERIGLFTRE / RIGL
Capitalization876M705M124%
EBITDA-858.4M109M-788%
Gain YTD-48.257133.710-36%
P/E RatioN/A7.24-
Revenue2.73B268M1,020%
Total Cash81.2M108M75%
Total Debt1.24B61M2,034%
FUNDAMENTALS RATINGS
RIGL: Fundamental Ratings
RIGL
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
73
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FTRERIGL
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
N/A
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 9 days ago
84%
Declines
ODDS (%)
Bearish Trend 10 days ago
85%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JPVZX17.96N/A
N/A
JPMorgan Developed International ValueR2
MXXIX61.16N/A
N/A
Marsico Midcap Growth Focus Fund
WSTYX74.22N/A
N/A
Macquarie Science and Technology Y
VYSDX11.04N/A
N/A
Voya Small Company R
BILSX10.16N/A
N/A
BlackRock U.S. Insights Lon/Shr Eq Ins

FTRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with TECH. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
+6.87%
TECH - FTRE
43%
Loosely correlated
-3.36%
SYRE - FTRE
41%
Loosely correlated
-2.45%
ADVM - FTRE
40%
Loosely correlated
-0.33%
XNCR - FTRE
40%
Loosely correlated
+0.37%
JAZZ - FTRE
40%
Loosely correlated
+1.37%
More

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been loosely correlated with MNMD. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if RIGL jumps, then MNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
-1.06%
MNMD - RIGL
41%
Loosely correlated
-0.71%
AGIO - RIGL
39%
Loosely correlated
-2.78%
FTRE - RIGL
38%
Loosely correlated
+6.87%
DNLI - RIGL
37%
Loosely correlated
+0.32%
MIRM - RIGL
36%
Loosely correlated
+1.18%
More